Publications by authors named "P P G van Benthem"
Objective: Serial intralesional steroid injections (SILSI) are increasingly used in the treatment of idiopathic subglottic stenosis (iSGS) and auto-immune related subglottic stenosis (SGS), which are both known for their high rate of recurrences. SILSI could potentially prolong the time to re-intervention. We evaluated the effects of adjuvant SILSI in iSGS and auto-immune related SGS-patients on time to reintervention and spirometry results.
View Article and Find Full Text PDFIntroduction: Knowledge of the natural and temporal course of a disease is important when deciding if an intervention is appropriate. In the case of Ménière's disease (MD), there is some evidence that attacks diminish over time, but the topic remains controversial. A conservative approach to surgery is usually followed in northern Europe, and leads to strict patient selection before considering surgery.
View Article and Find Full Text PDFIntroduction: Intratympanic corticosteroids are commonly used in the treatment of Menière's disease (MD). However, few and small randomised controlled trials (RCT) on the effectiveness of intratympanic corticosteroids have been performed. A recent Cochrane review suggested that a well-conducted placebo-controlled RCT with a large study population is required to evaluate the effectiveness of the use of intratympanic corticosteroids in MD.
View Article and Find Full Text PDFArticle Synopsis
- - The study focused on identifying demographic and clinical factors that lead to recurrences of benign paroxysmal positional vertigo (BPPV) in patients within a year of treatment.
- - Researchers analyzed data from 139 participants, finding that around 34.5% experienced at least one recurrence, with multiple treatments for the initial episode and a history of gout being significant risk factors.
- - The results highlight that a sizable portion of patients treated for BPPV may experience recurrences, emphasizing the need for better understanding and management strategies for those at higher risk.
Purpose: Identifying outcome measurements instruments (OMIs) to evaluate treatment efficacy in patients with vocal fold atrophy and/or sulcus.
Methods: Systematic review of records published before March 2021 by searching Pubmed and EMBASE. Included studies reported on adults (> 18 year) with dysphonia caused by glottic insufficiency due to vocal fold atrophy with or without sulcus, who were enrolled into a randomized controlled trial, a non-randomized controlled trial, a case-controlled study or a cohort study.